Overexpression of xCT protects tumors from oxidative stress but also creates therapeutic opportunities: targeting xCT sensitizes cancers to radiotherapy and ferroptosis-inducing agents (He et al., 2025; Yan et al., 2023). This evidence concerns the gene SLC7A11 and cancer.